ArticleGlobal epidemiology2022

Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021.

Milena Suarez Castillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.